Cannabinoids for the control of experimental multiple sclerosis

Authors: Gareth Pryce

Company: Neuroimmunology Unit, Neuroscience & Trauma Barts and the London School of Medicine and Dentistry Queen Mary University of London UK

Year Published: 2010

Leave a Reply